How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/staphylococcus-aureus-urinary-tract-infection.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Staphylococcus Aureus Urinary Tract Infection — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Staphylococcus Aureus Urinary Tract Infection (disease) competitive landscape: 8 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

8 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Staphylococcus Aureus Urinary Tract Infection, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Augmentin 250	CLAVULANIC ACID	Dr Reddys Labs Inc	beta Lactamase Inhibitor		1984-01-01
Claforan	CEFOTAXIME	Sterimax	Cephalosporin Antibacterial		1981-01-01
Methocillin S	CLOXACILLIN	GSK	cloxacillin		1974-01-01
Cefaprin	cefapirin	Bristol-Myers Squibb	cefapirin	Sigma non-opioid intracellular receptor 1	1974-01-01
Trimethoprim	TRIMETHOPRIM	Dr Reddys Labs Sa	Sulfonamide Antimicrobial [EPC]	Dihydrofolate reductase	1973-01-01
Bactocill In Plastic Container	OXACILLIN	Apothecon		Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A, Prostaglandin G/H synthase 1, Prostaglandin G/H synthase 2	1971-01-01
Furacin	NITROFURAZONE	Takeda	nitrofurazone	Sterile alpha and TIR motif-containing protein 1	1945-01-01
MACRODANTIN	NITROFURANTOIN, MACROCRYSTALLINE	ALMATICA	Nitrofuran Antibacterial [EPC]	Mitochondrial pyruvate carrier 2, CDGSH iron-sulfur domain-containing protein 1, Glucose-6-phosphate 1-dehydrogenase

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 4 drugs in Staphylococcus Aureus Urinary Tract Infection
ALMATICA · 1 drug in Staphylococcus Aureus Urinary Tract Infection
Apothecon · 1 drug in Staphylococcus Aureus Urinary Tract Infection
Bristol-Myers Squibb · 1 drug in Staphylococcus Aureus Urinary Tract Infection
Dr Reddys Labs Inc · 1 drug in Staphylococcus Aureus Urinary Tract Infection
Dr Reddys Labs Sa · 1 drug in Staphylococcus Aureus Urinary Tract Infection
GSK · 1 drug in Staphylococcus Aureus Urinary Tract Infection
Sterimax · 1 drug in Staphylococcus Aureus Urinary Tract Infection
Takeda · 1 drug in Staphylococcus Aureus Urinary Tract Infection

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Staphylococcus Aureus Urinary Tract Infection:

Cite this brief

Drug Landscape (2026). Staphylococcus Aureus Urinary Tract Infection — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/staphylococcus-aureus-urinary-tract-infection. Accessed 2026-06-10.

Staphylococcus Aureus Urinary Tract Infection full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing